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Abstract The current study aimed to investigate the
Autism Diagnostic Interview-Revised (ADI-R) algorithms
for toddlers and young preschoolers (Kim and Lord, J
Autism Dev Disord 42(1):82–93, 2012) in a non-US sam-
ple from ten sites in nine countries (n = 1,104). The con-
struct validity indicated a good fit of the algorithms. The
diagnostic validity was lower, with satisfactorily high
specificities but moderate sensitivities. Young children
with clinical ASD and lower language ability were largely
in the mild-to-moderate or moderate-to-severe concern
ranges of the ADI-R, nearly half of the older and phrase
speech ASD-group fell into the little-to-no concern range.
Although broadly the findings support the toddler algo-
rithms, further work is required to understand why they
might have different properties in different samples to
further inform research and clinical use.
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Introduction
Parallel to the increased evidence for the effectiveness of
early intervention for children with autism spectrum dis-
orders (ASDs; Oono et al. 2013), great improvements have
been accomplished in early recognition and diagnosis of
ASD (Al-Qabandi et al. 2011; Oosterling et al. 2010c;
Yirmiya and Charman 2010; Zwaigenbaum et al. 2013).
Diagnostic instruments such as the Autism Diagnostic
Observation Schedule (ADOS; Lord et al. 1999) and later
ADOS-Second Edition (ADOS-2; Lord et al. 2012a, b) and
the Autism Diagnostic Interview-Revised (ADI-R; Rutter
et al. 2003b) have evolved over the years. They now pro-
vide valuable information for clinicians in order to estab-
lish an early diagnosis (Charman and Gotham 2013). For
the ADOS-2, the revised algorithms for modules 1 and 2
and the algorithms for the Toddler module have shown
significant value in the early diagnosis of ASD (Gotham
et al. 2007, 2008; Luyster et al. 2009; Molloy et al. 2011;
Oosterling et al. 2010b, Overton et al. 2008).
The ADI-R is known to be reliable in older children (Lord
et al. 1994). However, for younger children the existing
algorithm was not optimal (e.g. Lord et al. 1993; Oosterling
et al. 2010a; Risi et al. 2006; Ventola et al. 2006; Wiggins and
Robins 2008). Recently, Kim and Lord (2012) proposed
new algorithms for toddlers and preschool children, aged
12–47 months, aiming to improve ADI-R validity for these
young children. The algorithms were developed in a large US
dataset (Michigan sample, N = 829) of toddlers and
preschoolers aged 12–47 months, with a nonverbal mental
age from 10 months and higher. The algorithms for toddlers
and preschoolers have been constructed in line with the
revised algorithms of the ADOS-2 (Gotham et al. 2007) and
the DSM-5 ASD criteria (APA 2013). They are more
specific, since the algorithms contain slightly different items
for different developmental groups based on age and lan-
guage level. These developmental groups, referred to as
developmental ‘cells’, are defined as (a) all children
12–20 months of age as well as nonverbal children
21–47 months of age (12-20/NV21-47), (b) all children
21–47 months with single words (SW21-47), and (c) all
children 21–47 months with phrase speech (PH21-47).
The new algorithms are shorter (13–20 items) than the
original algorithms (33–39 items) and contain three do-
mains. The algorithms are based on items from the stan-
dard ADI-R version (Rutter et al. 2003b) that also appear in
the toddler version (Kim and Lord 2012). The first domain
is the Social Affect Domain (SA; cells 12-20/NV21-47 and
SW21-47) or the Social Communication Domain (SC; cell
PH21-47), which contains items on social interaction and
communication. The second domain is the Restrictive,
Repetitive Behavior domain (RRB). The third domain is
either Imitation, Gesture and Play (IGP; 12-20/NV21-47
and SW21-47) or Reciprocal and Peer Interaction (RPI;
cell PH21-47). For the 12-20/NV21-47 and the SW21-47
cells algorithm cutoffs are based on two domains, namely
SA and RRB. The IGP domain was not included in the
algorithm in these cells, because it did not discriminate
ASD from non-spectrum diagnoses or typically developing
children when age, IQ and the other domains were included
in the analyses. For the PH21-47 cell cutoffs are based on
all three domains.
For each developmental cell two cutoffs for ASD versus
non-ASD have been defined: one for research (higher
threshold, more restrictive; higher specificity, lower sen-
sitivity) and one for clinical use (lower threshold, more
inclusive; higher sensitivity, lower specificity). Additional
to the classification based on these cutoffs, ranges of con-
cern have been provided, reflecting little-to-no, mild-to-
moderate, or moderate-to-severe concern, in order to rep-
resent the severity of autism symptoms.
The algorithm development study of Kim and Lord (2012)
in the Michigan sample indicated a good fit of the three factor
structure in all three developmental cells. It also showed
improved diagnostic validity of the ADI-R classification
based on the clinical and research cutoffs with a best estimate
clinical ASD diagnosis as the criterion, compared to the
original algorithm. The ADI-R classifications showed high
sensitivities (ADI-R clinical cutoff .80–.94, research cutoff
.80–.84) and specificities (ADI-R clinical cutoff .70–.81,
research cutoff .82–.90). Correlations between scores on the
algorithms and age and level of functioning indicated rela-
tive independence of these characteristics.
The authors have replicated the algorithms in two in-
dependent US samples (both described in Kim et al. 2013).
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One study had a relatively large (CPEA/STAART,
N = 641), the other a smaller sample size (NIMH,
N = 167). In both studies, the three factor structure was
well replicated. The specific developmental cells were
found to be applicable and correlations between participant
characteristics and algorithm scores remained low. Addi-
tionally, the improved diagnostic validity of the ADI-R
toddler algorithms was confirmed. Within the CPEA/
STAART sample, sensitivities were comparable to the
Michigan sample, and specificities were noticeably im-
proved. Within the NIMH sample sensitivities were higher
compared to the Michigan sample, and specificities were
comparable, except for the 12-20/NV21-47 group which
showed a slightly lower specificity. Of note is that in all US
samples, differentiating children with ASD from those re-
ferred for ASD but who received non-spectrum diagnoses,
was difficult.
Logistic regressions in the CPEA/STAART sample
confirmed an independent contribution of the SA and SC
domains to the ASD classification based on the ADI-R
toddler algorithms in all developmental cells. Independent
contribution of RRB varied over the developmental cells:
for older and more able children, the RRB items con-
tributed significantly to an ASD classification whereas for
younger and/or more impaired children this was less the
case.
In line with the Michigan sample, over 80 % of the
children with ASD in the CPEA/STAART sample fell into
the two ranges of clinical concern. The percentage of NS
cases in the risk ranges was lower than in the Michigan
sample. Because of limited sample sizes within cells, lo-
gistic regressions and ranges of concern have not been
examined for the NIMH sample.
Application of the ADI-R toddler algorithms in other
samples across sites, with independent, well-defined
populations with and without ASD is important in inves-
tigating the generalizability of the ADI-R toddler algo-
rithms (Kim and Lord 2012).
The current paper aims to make a modest contribution to
examining aspects of the validity of the ADI-R algorithms
for toddlers and preschoolers as proposed by Kim and Lord
(2012): the factor structure and sensitivity and specificity.
This is attempted in a large, fully independent, varied, non-
US sample (N = 1,104). In addition, use of clinical and
research cutoffs as well as ranges of concern were
evaluated. This study was initiated and realized within the
European network: ESSEA (Enhancing the Scientific Study
of Early Autism) COST action (European Cooperation in
Science and Technology). This network strives to establish
an interdisciplinary scientific network to advance the pace
of discovery on the earliest signs of autism (Bo¨lte et al.
2013); to combine techniques from cognitive neuroscience
with those from the clinical sciences; and to generate
European practice guidelines on early identification and
intervention (for more information, see: www.cost-essea.
com).
Methods
Participants
All sites of the COST-ESSEA network (consisting of 80
scientists in 23 countries) were invited to contribute ex-
isting databases to participate in the current study. Ten sites
that had relevant data to contribute participated, resulting
in the collection of 1,187 cases outside the US. To be
included in the current sample, the toddlers and young
preschoolers had to be between 12 months and 47 months
30 days old with nonverbal mental ages from 10 months
and higher, had to have an ADI-R available with scores on
all domains as specified for developmental cell and had to
have received a best clinical estimate diagnosis (BCE),
resulting in an N of 1,104. Additionally, research reliability
of administration and scoring of the ADI-R was required.
The sample (74.0 % males) had a mean age of 34.6
months (SD = 8.06). Just over half of the children (56.1 %)
had a BCE ASD diagnosis. Due to the young age of the
sample and in line with DSM-5, no differentiation was made
between autistic disorder (AD) and non-autism ASD (-
formerly, pervasive developmental disorder). Another
24.5 % had a non-spectrum diagnosis (NS) and 19.5 % were
typically developing (TD). The 12-20/NV21-47 cell mainly
consisted of children with ASD (N = 263) with 60 children
with NS disorders and only seven TD children, included for
determining sensitivity and specificity. The SW21-47 cell
contained 192 cases with ASD, 90 with NS disorders and 42
TD. In the PH21-47 cell, 36.4 % had an ASD (N = 164),
with almost equally many with NS disorders (120) and TD
(166). The non-spectrum diagnoses were classified follow-
ing Kim and Lord (2012) as: language delay (N = 112),
nonspecific intellectual disability (N = 39), Attention Def-
icit/Hyperactivity Disorder (ADHD; N = 34), nonspecific
developmental delay (N = 28), anxiety or internalizing
emotion regulation problems (N = 27), externalizing emo-
tion regulation problems (N = 10), attachment (N = 2) and
other (N = 18). In Table 1, the participant characteristics
are presented for the total sample.
Since the ESSEA network was formed in order to gen-
erate European practice guidelines on early identification
and intervention (amongst other things), existing datasets
from the participating sites did not fully match in character,
background and diagnostic procedure. The total sample
thus consists of children from various settings and char-
acteristics per site are presented in Table 2. The 10 par-
ticipating sites are:
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Table 1 Participant characteristics
Clinical classification 12-20/NV21-47 SW21-47 PH21-47
N Mean SD N Mean SD N Mean SD
ASD
Age (months) 263 32.2a,b 7.4 192 36.1a,c 6.5 164 40.2c 4.8
NVIQ 230 57.7d,e 19.0 164 69.4d,e 19.0 136 81.9d,e 19.0
ADI SA/SC 263 11.6c,f 3.9 192 9.8c,f 4.2 164 8.6c,f 4.6
ADI RRB 263 3.3f 2.5 192 3.5c,f 3.0 164 2.9c,f 2.5
ADI IGP/RPI 263 10.4c,f 2.3 192 6.7c,f 2.5 164 2.8c,f 1.6
ADI tot2dom 263 14.9 5.5 192 13.3 6.2 164 11.5 6.0
ADI tot3dom 263 25.2 7.1 192 20.0 8.0 164 14.3 7.1
ADOS T NW SA – – –
ADOS T NW RRB – – –
ADOS T SW SA 1 22.0 1 6.0 –
ADOS T SW RRB 1 5.0 1 14.0 –
ADOS 1 NW SA 135 14.8f 3.3 62 12.5 3.1 13 11.2a 3.1
ADOS 1 NW RRB 135 3.4f 1.9 62 2.4 1.8 13 1.8c,f 1.6
ADOS 1 SW SA 60 16.4 3.1 98 12.6c,f 4.5 75 10.4c,f 5.0
ADOS 1 SW RRB 60 3.8 1.6 98 2.4f 1.7 75 2.5c,f 1.8
ADOS 2 SA – 3 14.7 4.2 59 10.5c,f 4.5
ADOS 2 RRB – 3 4.7 1.5 59 2.7c,f 2.3
Non-spectrum disorders
Age (months) 60 25.6a 9.3 90 33.4a,g 7.7 120 38.1h 6.0
NVIQ 44 74.0d,i 25.1 81 82.6d,j 18.8 116 93.1d,j 16.7
ADI SA/SC 60 3.6f 3.1 90 4.8f,g 3.6 120 4.2f,g 3.8
ADI RRB 60 .9f 1.5 90 1.3f 1.9 120 1.4f,h 1.9
ADI IGP/RPI 60 4.5f 3.6 90 3.7f,g 2.5 120 2.1f,g 1.6
ADI tot2dom 60 4.5 4.0 90 6.1 4.4 120 5.6 4.9
ADI tot3dom 60 8.9 6.9 90 9.8 6.1 120 7.7 5.9
ADOS T NW SA – 4 7.3 6.9 –
ADOS T NW RRB – 4 2.3 1.3 –
ADOS T SW SA 2 5.0 7.1 2 4.0 1.4 3 5.0 6.2
ADOS T SW RRB 2 .5 .7 2 .5 .7 3 2.7 .6
ADOS 1 NW SA 34 5.1f 5.0 18 7.4 4.9 2 4.5a .7
ADOS 1 NW RRB 34 1.0f 1.4 18 1.2 1.4 2 1.0f,h 1.4
ADOS 1 SW SA 8 2.9 1.7 41 4.5f 3.8 62 3.8f 3.0
ADOS 1 SW RRB 8 .6 .7 41 1.0f 1.2 62 .6f .8
ADOS 2 SA 6 2.7 4.6 39 5.4f,g 3.2
ADOS 2 RRB 6 .7 .8 39 1.2f,h 1.4
Typical development
Age (months) 7 22.3b 7.3 42 26.4c,g 5.3 166 35.1d,h 8.5
NVIQ 7 97.7e,i 20.4 41 101.4e,j 12.3 164 109.3e,j 13.2
ADI SA/SC 7 4.1c 5.3 42 1.8c,g 3.0 166 1.0c,g 1.8
ADI RRB 7 1.6 2.1 42 1.0c 1.8 166 .7c,h 1.2
ADI IGP/RPI 7 4.4c 4.5 42 1.6c,g 1.8 166 .6c,g .9
ADI tot2dom 7 5.7 7.4 42 2.8 4.3 166 1.7 2.5
ADI tot3dom 7 10.1 11.8 42 4.5 5.6 166 2.3 3.0
ADOS T NW SA 2 1.5 2.1 15 2.5 3.0 24 1.5 1.8
ADOS T NW RRB 2 .5 .7 15 .9 1.2 24 .5 .7
ADOS T SW SA 2 1.5 2.1 18 1.4 1.3 36 1.4 1.7
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1. Sweden, the Neuropsychiatric Resource Team
Southeast, Division of Child and Adolescent Psy-
chiatry, Stockholm County Council; N = 234 (see
Zander et al. 2014),
2. The Netherlands Nijmegen, University Center for
Child and Adolescent Psychiatry, N = 230 (see
Oosterling et al. 2010c),
3. The Netherlands Utrecht, University Center for
Child and Adolescent Psychiatry, N = 42,
4. Israel, the Hebrew University of Jerusalem,
N = 206,
5. United Kingdom, Preschool Autism Communica-
tion Trial study (PACT; Green et al. 2010) N = 92;
CHAT screening study (Baird et al. 2000) N = 27;
CHAT intervention study (Drew et al. 2002)
N = 26; PPP study (unpublished data) N = 43);
total N = 188,
6. Spain, the Salamanca University ASD Unit,
N = 115 (see Canal-Bedia et al. 2011),
7. Iceland, the State Diagnostic and Counseling
Center, N = 39,
8. Macedonia, the University Clinic of Psychiatry,
N = 20,
9. France, the University of Toulouse and CeRESA,
an organization for diagnosis and intervention for
ASD, N = 17, and
10. Finland, Oulu University Clinic of Child Psy-
chiatry, N = 13.
Measures and Procedures
Enrollment and Site Differences
In Table 3, the procedures of enrollment and the diagnostic
procedures are presented for all sites.
The sites included children from various backgrounds:
some samples were based on diagnostic assessment of
toddlers/children considered ‘at risk’ of ASD following
screening in general or high risk populations (NL Ni-
jmegen, part of the UK, Spain, Finland), whereas others
were based on diagnostic assessment of clinical referrals
for ASD or other developmental problems based on par-
ental and/or professional concern (Sweden, NL Utrecht,
Iceland, Macedonia, France). The children from Israel were
included for research into the relationship between use of
medication by mothers during pregnancy and social
Table 1 continued
Clinical classification 12-20/NV21-47 SW21-47 PH21-47
N Mean SD N Mean SD N Mean SD
ADOS T SW RRB 2 0 0 18 .8 1.4 36 .5 .8
ADOS 1 NW SA 2 10.0 7.1 – 2 12.0c,h 0
ADOS 1 NW RRB 2 4.5 3.5 – 2 2.0 2.8
ADOS 1 SW SA 1 1.0 7 5.3c 5.2 33 1.7c 2.0
ADOS 1 SW RRB 1 0 7 1.3 2.1 33 .6c .9
ADOS 2 SA – – 66 1.3c,g 1.5
ADOS 2 RRB – – 66 .4c,h .7
12-20/NV21-47 all children from 12 through 20 months and nonverbal children from 21 through 47 months; ADItot2dom total score on SA/
SC ? RRB domains combined; ADItot3dom total score on SA/SC ? RRB ? IGP/RPI domains combined; IGP Imitation, Gestures and Play
Total for the 12-20/NV21-47 and SW21-47 algorithms; PH21-47 Children from 21 through 47 months with phrase speech; RPI Reciprocal and
peer Interaction total for the PH21-47 algorithm; RRB Restricted and repetitive Behaviors Total; SA Social affect Total for the 12-20/NV21-47
and SW21-47 algorithms SC Social Communication Total for the PH21-47 algorithm; SW21-47 Children from 21 through 47 months with single
words
Significant differences with Bonferroni correction
a ASD[NS p\ .05
b ASD[TD p\ .05
c ASD[TD p\ .001
d NS[ASD p\ .001
e TD[ASD p\ .001
f ASD[NS p\ .001
g NS[TD p\ .001
h NS[TD p\ .05
i TD[NS p\ .01
j TD[NS p\ .001
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communicative development and temperament of their
children after birth. They were not considered at risk for
ASD for research or clinically and were recruited from the
general population, however, a large proportion was born
prematurely. These children were included for determining
sensitivity and specificity.
Additionally, as shown in Table 2, not all of the sites
had data in all three developmental cells, or the numbers
were too small for reliable and valid analyses with the
revised algorithms. The sample of N = 7 in the 12-20/
NV21-47 TD cell is very small even in the total sample.
Also, the composition of the data differed over sites. For
example, while most sites included children with ASD as
the majority (over 58 % in eight out of 10 sites, with five
over two-thirds), in the other two subsamples TD was
dominant. Another example is that the Finnish sample
contained children who were clinically referred for con-
cerns on ASD based on population screening, but who were
not diagnosed with ASD (yet) after a thorough diagnostic
procedure. At the same time, the sample from Israel con-
tained children who were not specifically at risk for ASD.
Best Clinical Estimate Diagnosis (BCE)
For all toddlers and young preschoolers, a clinical diag-
nosis was based on thorough diagnostic procedures in ex-
pert teams including at least a child psychologist and/or
child psychiatrist (see Table 3 for specific procedures and
disciplines).
Autism Diagnostic Interview-Revised (ADI-R)
All toddlers and young preschoolers in the study had been
administered an ADI-R, by a trained psychologist, psy-
chiatrist or speech and language pathologist with research
reliability in administration and scoring of the interview.
Most often the standard ADI-R was administered and in
249 cases (Israel and UK CHAT study) the toddler ADI-R
was administered. In Sweden, the Netherlands, Finland,
Spain, France and Israel, an officially translated, approved
and published ADI-R was available. In Iceland and
Macedonia a translated and approved version of the ADI-R
was available although this had not been published.
The mean ADI-R domain scores (Table 2) varied over
the sites. These scores did not seem to be systematically
related to recruitment method. For example, the first two
samples differed in background, yet had relatively com-
parable mean domain scores. Compared to the US samples,
in the current sample, ASD children had relatively low
scores on the SA/SC domain, especially in the PH21-47
cell. Additionally, the NS children from the current sample
seemed to have relatively high scores on the SA/SC do-
main. Furthermore, all RRB scores seemed to be relatively
low. However, the differences between the current and the
US samples could not be formally tested, since the original
datasets of the US samples would have been needed for
that.
Non-verbal Level of Functioning
Level of nonverbal cognitive functioning was available for
983 cases (89 %), most often measured with the Mullen
Scales of Early Learning (MSEL; Mullen 1995), the Mer-
rill-Palmer–Revised Scales of Development (Roid and
Sampers 2005), or the PEP-R (Schopler et al. 1990). For
the Mullen, NVIQ was based on fine motor (FM) and vi-
sual reception (VR) age equivalents: NVIQ = (mean age
equivalent on FM and VR/chronological age in months) 9
100. For the Merrill-Palmer, NVIQ was calculated as
(mean age equivalent on cognitive and fine motor/
chronological age in months) * 100. For the PEP-R, NVIQ
was calculated as: (mean developmental age in months on
all subscales except for the verbal scale/chronological age
in months) * 100. The mean NVIQ differs over the sites,
ranging from 40.4 to 113. This is important, since the level
of NVIQ might have influenced scores on the ADI-R if
these were correlated in the current sample. In that case,
the differences in NVIQ might explain the differences in
mean domain scores on the ADI-R. Pearson r correlations
seemed to indicate that the domain scores were slightly
more related to NVIQ in the UK and Spain samples than in
the Sweden and NL Nijmegen samples (Sweden: -.00
through -.30; NL Nijmegen: -.10 through -.29; UK: -.19
through -.65; Spain: -.17 through -.58). Macedonia had the
highest domain scores and the lowest NVIQ, however, the
n was too small for Pearson r correlation (5 in SW, 15 in
PH cell).
Design and Analyses
The current sample was divided into the three develop-
mental cells (12-20/NV21-47; SW21-47 and PH21-47) as
described by Kim and Lord (2012). Revised algorithm
scores and classifications were calculated for each case as
applicable with respect to developmental cell. For all
analyses, ADI-R item scores of 3 were transformed into 2.
Several analyses were performed in order to investigate
the ADI-R algorithms for toddlers and preschoolers. First,
we investigated the goodness of fit of the three factor
structure of the revised ADI-R algorithms, based on the
items they contain, with exactly the same Mplus (Muthe´n
and Muthe´n 2007) Confirmatory Factor Analysis model for
categorical data as applied in the algorithm development
study (2012) and the replication studies (2013). This was
applied to the whole sample, including ASD, NS and TD.
Second, also including all diagnostic groups, correlations
2084 J Autism Dev Disord (2015) 45:2076–2091
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between the algorithm scores and participant characteris-
tics were calculated in order to examine how independent
the algorithm scores were from NVIQ and age. Third,
sensitivity and specificity of the algorithms were calcu-
lated for the distinction between ASD and NS (without
TD), and outcomes were compared to the former studies.
This was done for the research criteria and the clinical
criteria separately. Kim and Lord (2012) created the two
sets of criteria in order to be able to decide which would
be most appropriate for a specific setting. The clinical
cutoffs aim for maximum sensitivity with adequate
specificity, whereas the research cutoffs aim for max-
imum specificity with adequate sensitivity. Depending on
whether the ADI-R is used to include possible cases, or
definite cases, a clinician can choose which cutoff to
apply. For some research aims it may be important to
include definite cases only, for example when time con-
suming and expensive research is conducted. On the other
hand, researchers investigating the broader spectrum may
want to include a group with milder symptoms as well.
With Receiver Operating Characteristic (ROC) analyses,
the effect of including the IGP domains in the total scores
in the 12-20/NV21-47 and SW21-47 cells, and of omitting
the RPI score for the PH21-47 cell was examined on the
balance between sensitivity and specificity. For these
analyses, following the study of Kim and Lord (2012),
TD was excluded in order to prevent artificial increase of
the sensitivity and specificity. Fourth, the applicability of
the ranges of concern proposed by Kim and Lord (2012)
was investigated in the current sample. Therefore, we
compared the percentages of children with a clinical
ASD, NS or TD diagnosis within each range to those in
each range in the former studies. Last, in order to in-
vestigate the predictive value of the revised algorithm
domains, logistic regressions were performed in the
sample with a clinical ASD or NS diagnosis. TD was not
included in this comparison due to comparability with the
former studies. Additionally, comparing TD and ASD
does not resemble clinical practice. Due to the diagnostic
group differences on age and NVIQ (see Table 1), logistic
regression analyses were applied with age and NVIQ in
the analyses, comparable to the CPEA/STAART study
(Kim et al. 2013).
Results
Confirmatory Factor Analyses
Table 4 shows the proposed three factor solution of the
revised algorithm in the current sample. This solution had
satisfactory indices of goodness of fit in all developmental
cells: Comparative Fit Indices (CFI) ranged from .889 to
.929 (CFI between .9 and 1.0 indicates a good fit of the
proposed model) and the Root Mean Square Error Ap-
proximations (RMSEA) ranged from .055 to .063 (RMSEA
below.08 indicates a satisfactory goodness of fit). Corre-
lations between factors were .68–.90 for the 12-20/NV21-
47 cell, .64–.92 for the SW21-47 cell and .67–.83 for the
PH21-47 cell. In all cells, correlations between the SA/SC
factor and the IGP/RPI factor were the highest.
Correlations with Participant Characteristics
Correlations of ADI-R algorithm domain scores with age
did not exceed an r of .4 in any of the developmental cells.
With NVIQ, correlations did not exceed an r of .5. Ex-
cluding children with TD from the analyses lead to slightly
lower correlations (r\ .4 for age and NVIQ).
Sensitivity and Specificity
Sensitivity and specificity could only be calculated for
ASD versus non-spectrum, since no differentiation be-
tween autistic disorder (AD) and non-autism ASD (e.g.
pervasive developmental disorder—not otherwise speci-
fied) had been made within the ASD group. The outcomes
are presented in Table 5.
In the 12-20/NV21-47 cell, specificity for ASD was
high, .93 for the clinical and .95 for the research algorithm
cutoff. Sensitivity in this cell was .78 for the clinical and
.66 for the research cutoff.
In the SW21-47 cell, the clinical cutoff was associated
with a specificity of .70, with a sensitivity of .80, and the
research cutoff resulted in a higher specificity (.89) with a
low sensitivity of .53. In the PH21-47 cell, the specificity
was again highest for the research criteria (.93) with a
sensitivity of .45 only, and lower for the clinical criteria
(.81), with a sensitivity of .56.
Further investigation of the separate sensitivities was
undertaken for those sites with a sample size of over a
hundred cases and enough children with ASD and NS
(Sweden; NL Nijmegen; UK; and Spain). The large ma-
jority of the data from Israel represented TD, therefore,
sensitivity and specificity were not calculated for this
sample. Sensitivities varied over the sites: in the Nether-
lands and Sweden .31–.47 for research cutoffs and .47–.71
for clinical cutoffs; in the UK and Spain .64–.91 for re-
search cutoffs and .64–.98 for clinical cutoffs.
Based on the ROC analyses, the Areas under the Curve
(AuC) indicated that the algorithms as proposed by Kim
and Lord (2012) were valid when comparing a clinical
diagnosis of ASD versus non-spectrum [AuC.93 (95 % CI
.90–.97) for 12-20/NV21-47; AuC.83 (95 % CI .78–.88)
for SW21-47; AuC.77 (95 % CI .71–.82) for PH21-47].
These analyses investigated a continuous measure of
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criterion related validity, based on the total scores of two or
three domains (the total scores on the proposed algorithms
in each cell). Note that the domains were not examined
separately. Experimentally adding the IGP domain items to
the total score for the 12-20/NV21-47 and SW21-47 cell
resulted in an AuC that resembled the one based on the two
domain total score [.94 (95 % CI .90–.97) for 12-20/NV21-
47;.84 (95 % CI .79–.89) for SW21-47]. Excluding the RPI
domain items from the total score for the PH21-47 cell also
resulted in a comparable AuC (.78; 95 % CI .73–.84).
Adding or omitting the IGP/RPI domain items thus did not
seem to affect the sensitivity or specificity over the range
of total scores on two or three domains combined in the
current sample.
Ranges of Concern
The ranges of concern as defined by Kim and Lord (2012),
aiming for 80 % of the children with ASD in the ranges of
mild-to-moderate or moderate-to-severe concern and 95 %
of the TD children in the little-to-no concern range, seemed
more or less applicable to the 12-20/NV21-47 and SW21-
47 developmental cells in the current sample: In the 12-20/
NV21-47 cell, 77.2 % of the 246 children with ASD fell
Table 4 New ADI-R algorithm loadings in non-US sample
12-20/NV21-47 Factor
loadings
SW21-47 Factor
loadings
PH21-47 Factor
loadings
Social affect Social affect Social affect
C. Attention to voice .82 C. Attention to voice .70 C. Attention to voice .69
C. Direct Gaze .80 C. Direct Gaze .79 C. Direct Gaze .80
C. Social Smiling .77 C. Social Smiling .75 C. Nodding to mean yes .69
C. Seeking to share enjoyment .68 C. Seeking to share enjoyment .65 C. Seeking to share enjoyment .78
C. Range of facial expression .80 C. Range of facial expression .79 C. Range of facial expression .78
C. Inappropriate facial expression .56 C. Inappropriate facial expression .63 C. Offers comfort .72
C. Appropriateness of social
response
.81 C. Appropriateness of social
response
.73 C. Pointing .76
C. Interest in children .85 C. Interest in children .71 C. Directing attention .80
C. Response to approaches of
children
.81 C. Response to approaches of
children
.75 C. Quality of social overtures .82
C. Quality of social overtures .77 C. Social chat .79
C. Use of other’s body .54
Repetitive and restricted behaviors Repetitive and restricted behaviors Repetitive and restricted behaviors
E. Repetitive use of objects .81 E. Repetitive use of objects .89 C. Stereotyped language .87
E. Hand mannerisms .65 E. Hand mannerisms .74 E. Hand mannerisms .74
E. Complex mannerisms .79 E. Complex mannerisms .75 E. Complex mannerisms .68
E. Unusual sensory interests .75 E. Unusual sensory interests .73 E. Unusual sensory interests .56
E. Unusual preoccupations .55 E. Unusual preoccupations .31
E. Compulsions/rituals .51 E. Compulsions/rituals .42
Imitation, gestures and play Imitation, gestures and play Reciprocal and peer interaction
C. Pointing .81 C. Pointing .80 C. Appropriateness of social
response
.77
C. Gestures .86 C. Gestures .80 C. Interest in children .83
C. Imitation of actions .82 C. Imitation of actions .76 C. Response to approaches of
children
.92
C. Offering to share .79 C. Offering to share .67
C. Imaginative play .83 C. Imaginative play .79
C. Directing attention .90
CFI: .929 (.952a, .948b, .852c) CFI: .889 (.943a, .908b, .892c) CFI: .912 (.960a,.913b, .806c)
RMSEA: .060 (.069a, .057b, .084c) RMSEA: .063 (.062a, .077b, .066c) RMSEA: .055 (.053a, .053b, .093c).
a Values from Kim and Lord (2012)
b Values from Kim et al. (2013), CPEA sample
c Values from Kim et al. (2013), NIMH sample
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into the ranges of mild-to-moderate or moderate-to-severe
concern and in the SW21-47 cell 79.7 %. Of the TD
children 90.5 % in the SW21-47 cell fell into the no-to-
little concern range. In the 12-20/NV21-47 there were only
7 children in the TD group, therefore the number in this
cell is too small to analyze reliably. Of the NS children,
6.6 % in the 12-20/NV21-47 and 30 % in the SW21-47 cell
fell into the risk ranges, percentages that fell within the
ranges in the Michigan sample (30–33 %; 2012) and
CPEA/STAART sample (6–16 %; 2013). For the PH21-47
cell the results were somewhat different. Whereas 98.2 %
of the TD group and 80.8 % of the NS children fell into the
little-to-no concern range, only 56.1 % of the children with
ASD fell into one of the risk ranges. This means that
43.9 % of children diagnosed with an ASD in the current
sample fell into the little-to-no concern range, with total
scores of 12 or lower on the ADI-R algorithm.
Logistic Regressions
Logistic regressions could only be performed for children
for who NVIQ was available. With logistic regressions, the
contribution of the individual domains to a clinical clas-
sification of ASD versus NS was investigated, with all
other domains, age and NVIQ in the analyses. In the cur-
rent sample, the SA/SC domains contributed significantly
to a clinical diagnosis of ASD versus NS in all develop-
mental cells [12-20/NV21-47 odds ratio (OR) 1.44, 95 %
CI 1.20–1.72, p\ .001; SW21-47 OR 1.26, 95 % CI
1.12–1.42, p\ .001; PH21-47 OR 1.27, 95 % CI
1.16–1.40, p\ .001]. The RRB domain did not affect di-
agnosis in the 12-20/NV21-47 group (OR .95, 95 % CI
.69–1.30; p = .742) or in the PH21-47 cell (OR 1.11, 95 %
CI .95–1.30, p = .196), yet it made a significant
contribution in the SW21-47 cell (OR 1.19, 95 % CI
1.01–1.41, p = .041). In the 12-20/NV21-47 cell, the IGP
domain additionally contributed to the clinical diagnosis,
with an OR of 1.34 (95 % CI 1.11–1.62; p = .002), in the
SW21-47 cell IGP contributed too (OR 1.20, 95 % CI
1.02–1.40, p = .025) yet in the PH21-47 cell RPI did not
add to a diagnosis (OR .91, 95 % CI .73–1.13, p = .368).
These analyses revealed that all individual domains inde-
pendently contributed to the identification of children with
ASD, yet that their roles varied over cells.
Discussion
The current paper aims to make a modest contribution to
the literature by examining aspects of the validity of the
ADI-R algorithms for toddlers and preschoolers (Kim and
Lord 2012) in an independent and large non-US sample
(N = 1,104). With respect to construct validity, the three
factor structure as found by Kim and Lord (2012) fitted the
data well. In the current sample, the specific items fitted
well into the specific ADI-R toddler and preschooler do-
mains, in line with the values of Kim and Lord and the
replication studies (Kim et al. 2013). The fit indices of the
three factor model were satisfactory to good, resembling
the ones in the US samples and indicating that the new
ADI-R algorithm structure can be applied to the non-US
data. Correlations between factors were comparable to
those in the CPEA/STAART (r = .69–.94; Kim et al.
2013) and NIMH samples (r = .55–.99; Kim and Lord
2012) indicating the same high correlations between the
three factors. In particular the high correlations between
SA/SC and IGP/RPI indicated that these domains were not
independent from each other.
Table 5 Sensitivity and specificity of cutoff criteria ADI-R Toddler algorithms for ASD versus non-spectrum
Sensitivity non-US
sample
(95 % CI)
Sensitivity US
samples
Specificity non-US
sample
(95 % CI)
Specificity US
samples
12-20/NV21-47
Research cutoff = 13 .66 (.60–.72) .77a/.76b/.85c .95 (.86–.99) .85a/.94b/.64c
Clinical cutoff = 11 .78 (.72–.82) .85a/.85b/.90c .93 (.84–.98) .70a/.94b/.64c
SW21-47
Research cutoff = 13 .53 (.46–.60) .71a/.72b/.89c .89 (.81–.95) .90a/.92b/.89c
Clinical cutoff = 8 .80 (.73–.85) .94a/.96b/.97c .70 (.59–.79) .81a/.83b/.58c
PH21-47
Research cutoff = 16 .45 (.37–.53) .70a/.80b/.67c .93 (.86–.97) .82a/.94b/.86c
Clinical cutoff = 13 .56 (.48–.64) .80a/.89b/.89c .81 (.73–.87) .70a/.94b/.76c
a Values from Kim and Lord (2012), Michigan sample
b Values from Kim et al. (2013), CPEA sample
c Values from Kim et al. (2013), NIMH sample
J Autism Dev Disord (2015) 45:2076–2091 2087
123
Another finding that corroborated the construct validity
was the relatively low correlation between the algorithm
scores and age and level of cognitive functioning. The
levels of these correlations were comparable to those in the
Michigan study (r\ .5, most\ .4; Kim and Lord 2012),
and in the CPEA/STAART study (r\ .4; Kim et al. 2013)
and NIMH study (r B .4; Kim et al. 2013). Nevertheless,
the correlation between mean domain scores and NVIQ
varied over the sites, with relatively higher correlations for
the UK and Spain.
The criterion related validity of the algorithm scores as
proposed by Kim and Lord (2012) was satisfactorily high.
The proposed combination of domains for classification
(SA and RRB in 12-20/NV21-47 and SC, RRB and RPI in
PH21-47) corresponded with a clinical ASD diagnosis in
the current sample. Further investigation of this criterion
related validity indicated that the third factor (IGP/RPI)
was not a totally separate factor that reflected a crucial
behavioral domain for ASDs in the current sample, even
though it did contribute to a clinical classification. Adding
the IGP factor in the analyses for 12-20/NV21-47 or
SW21-47 cells or omitting the RPI factor in the PH21-47
cell did not affect the criterion related validity of the total
scores, which is understandable with the high correlation
between this domain and SA/SC (r = .83–.92 over the
developmental cells). This indicates that algorithm scores
based on the total of two or three domains were equally
valid compared to a clinical diagnosis of ASD in the tod-
dlers and preschoolers in the current sample. Kim and Lord
(2012) have reported that no third domain was needed for
the algorithm cutoffs in the12-20/NV21-47 and SW21-47
cells, but did include three domains for PH21-47. In the
current sample the third domain did not seem to add to the
criterion related validity for the PH21-47 cell either. If
further research in other independent samples replicated
this finding, it would potentially add to the comparability
of the algorithms over the cells (each consisting of two
rather than three domains), and enhance comparability of
scores over time within and between children. Overall, the
findings on construct validity indicate that the ADI-R
toddler algorithms are well applicable to the non-US data,
with valid content and factor structure.
With respect to diagnostic validity, the results from the
current study were less consistent with the original study.
The specificities for the clinical and research cutoffs in the
current sample resembled the ones in the US studies, except
in the SW21-47 cell, which had a lower specificity on the
clinical cutoff (.70). However, the sensitivities in the current
sample were lower for all developmental cells compared to
the original Kim and Lord (2012) study and the CPEA/
STAART and NIMH studies (Kim et al. 2013). In the 12-20/
NV21-47 cell, the 95 % CI’s of sensitivities overlapped
between the current and the US samples, therefore no firm
conclusion could be drawn regarding the significance of this
difference. In the SW21-47 and PH21-47 cells, the sensi-
tivities (both cutoffs) were significantly lower in the current
sample than in the Michigan and CPEA/STAART samples
as evidenced by the non-overlapping 95 % CI’s. Compared
to the NIMH sample, the sensitivity of the research cutoff in
the SW21-47 cell was significantly lower in this non-US
sample, however again no firm conclusion could be drawn
regarding the clinical cutoff, due to overlapping 95 % CI’s.
In the PH21-47 cell, the sensitivity of the clinical cutoff was
significantly lower in the current sample, yet the 95 % CI’s
of the research cutoff overlapped with the NIMH sample,
meaning no firm conclusion could be drawn on the sig-
nificance of this difference.
These findings indicate that although the content and
structure of the algorithms were applicable in the current
sample, the sensitivity of the ASD classification based on
the reported research and clinical cutoff scores was only
moderate and lower than in the Kim and Lord studies (Kim
and Lord 2012; Kim et al. 2013).
However, investigation of the ranges of concern re-
vealed that, in the 12-20/NV21-47 and SW21-47 cells, the
percentages of children with ASD in the mild-to-moderate
and moderate-to-severe ranges approached the ones in the
US samples. This indicates that children in these cells with
a clinical diagnosis of ASD were recognized as in the
concern range, and that the majority of children with TD
were indeed found to be in the little-to-no concern range. In
contrast, in the PH21-47 cell, only 56.1 % of the children
clinically diagnosed with ASD fell into the concern ranges,
which means that 43.9 % received a score on the ADI-R in
the range of little-to-no concern.
One explanation may be that for the PH21-47 cell, only
the SC domain contributed significantly to the clinical di-
agnosis, instead of contributions from each of the domains
(SC, RRB and RPI) as reported in the US samples, possibly
indicating a shift in what was important for a clinical di-
agnosis of ASD in the current sample. In the 12-10/NV21-
47 cell, the SA and the IGP domain individually con-
tributed, and in the SW21-47 cell all domains affected
ASD diagnosis.
The low sensitivity might be accounted for by the nature
of the current sample as compared to the US samples (Kim
and Lord 2012; Kim et al. 2013). Most likely, the fact that
more than half of the children had been recruited after
screening (N = 446; NL Nijmegen, part of UK, Spain,
Finland) instead of after clinical referral (N = 352; Swe-
den, NL Utrecht, Iceland, Macedonia, France) will have
influenced these results. The children from Israel were not
included in these numbers, since they were neither
clinically referred, nor recruited after screening, and pur-
posefully included as TD. Thus, around 40 % of the sample
were administered the ADI-R as part of diagnostic
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assessment in a prospective screening study. In the Michi-
gan, CPEA/STAART and NIMH samples, that were pri-
marily clinically referred samples, it might be expected at
this earlier age that symptoms were (on average) more severe
than in children identified as ‘at risk’ for autism by a
screening instrument. This may in part account for the lower
sensitivity we found in our sample. Perhaps, parents of
children identified through screening may be less aware of
some of the behaviors they are asked about during the ADI-
R. This may lead to lower scores on the ADI-R, although
other sources of information, including direct observation
and information from preschool or daycare, may identify
behaviors sufficiently suggestive of an ASD diagnosis. In
such cases, the ADI-R scores may be below threshold if the
parent is apparently unaware of the unusual behaviors. This
may apply particularly to parents of very young children.
The percentages of ASD diagnosis per site were higher
than the percentages of children with an ADI-R score
above clinical or research cutoff. Only in the UK sample,
the difference between diagnosis and percentage above
cutoffs was small. In other words, in some to relatively
many cases, the diagnostic teams had sufficient indication
to establish a clinical ASD diagnosis, even though parents
did not report severe problems during the ADI-R. This was
not only true for parents recruited through screening (e.g.
NL Nijmegen), but also for clinically referred children for
ASD or other developmental concerns (e.g. Sweden).
Therefore, the nature of recruitment/referral would be
unlikely to be the only explanation. Another consideration
might be the relatively low proportion of ASD versus NS
(excluding TD) in the SW21-47 and PH21-47 cells in the
Dutch, Swedish and Spanish samples (for SW21-47 72, 63
and 48 % ASD respectively; for PH 21-47 50, 52 and 46 %
ASD) compared to the US-samples (percentage ASD in
SW21-47 Michigan sample 81 %, CPEA/STAART 85 %
and NIMH 66 %; PH21-47 Michigan sample 63 %, CPEA/
STAART 88 % and NIMH 56 %). With the small sample
sizes per site, the focus needs to be on the general picture
of the combined dataset and not site-by-site variation.
The lower sensitivity of the research criteria in the
current sample than in the former studies (Kim and Lord
2012; Kim et al. 2013) might indicate that using the ADI-R
in the current sample as the criterion for inclusion for re-
search studies would have led to small numbers of children
included. However, with the satisfactory specificity, they
would be definite cases of ASD. Thus, as the authors de-
scribed (Kim and Lord 2012, p. 91) these criteria would be
helpful for researchers who need definite cases. However
for researchers investigating the broader range of ASDs,
the current findings indicate that the ADI-R may not be
very sensitive to identify cases of interest. As acknowl-
edged many times before by the authors of the ADI-R, the
ADI-R is not equivalent to the diagnosis and is meant to be
used as a tool in the diagnostic procedure and it should be
combined with information from other sources to result in a
BCE. The current findings suggest that if researchers want
to include the broader spectrum of ASDs in their research
sample, the ADI-R alone should not be used as the only
criterion. However, the current findings are probably due to
the nature of the samples and in the particular focus of any
given research study should drive decisions on inclusion
criteria in research samples.
The findings from the current study were only partly
consistent with the findings reported in the US studies. The
construct validity resembled former findings, the diagnostic
validity was less stable (lower sensitivity). This might
however be a consequence of recruitment/referral to the
current sample and of the relatively low scores on the ADI-
R of the children with a clinical ASD diagnosis. Despite
this uncertainty, especially for the 12-20/NV21-47 and
SW21-47 cells, the ADI-R algorithms for toddlers and
preschoolers were likely to be of considerable value in
aiding clinicians as they had to make diagnostic decisions
in very young children. At all sites in the current study,
clinical diagnoses were based on several sources of infor-
mation (in addition to the ADI-R and often ADOS) and
were assigned by an experienced expert, most often in a
team. Detailed information obtained using the ADI-R and
ADOS(-2) in a standardized diagnostic procedure has been
shown to make specific contributions to the clinical deci-
sion-making process (see Kim and Lord 2012; Kim et al.
2013; Charman and Gotham 2013).
Limitations
Although the total sample size of the current study was
large, the sample consisted of children from many different
sites and is thus not a true replication study, given the
different methodologies for assessment and diagnostic
procedures, and ascertainment of samples. The sites pro-
vided a wide variety of samples recruited for different
purposes (clinical referral/screening, first line/second line);
in diagnostic groupings (some TD only, others NS only,
others mainly ASD); from several populations (prediag-
nosed/undiagnosed; specialized departments/generic de-
partments); with a range in severity of symptoms, age
distribution (very young only versus broader), number of
participants and level of cognitive functioning. However,
unfortunately the individual sample sizes were too small to
allow any additional analysis for any individual sites.
Conclusion
The current study indicates that the construct validity of the
algorithms for toddlers and preschoolers as proposed by
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Kim and Lord (2012) was applicable in a large, indepen-
dent, non-US sample. The selected ADI-R items fitted into
the proposed domains SA/SC, RRB and IGP/RPI in the
non-US sample as well as in the US sample. This indicates
that the theoretical concept of the ADI-R in toddlers and
young preschoolers seemed to be the same for US and non-
US samples. However, in the current sample somewhat
lower diagnostic validity was found, with satisfactorily
high specificities but only moderate sensitivities. Although
children with a clinical ASD diagnosis in the 12-20/NV21-
47 and SW21-47 cells were largely recognized as children
in the mild-to-moderate or moderate-to-severe concern
ranges, nearly half of the children with a clinical ASD
diagnosis in the PH21-47 cell fell into the little-to-no
concern range.
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